2021
DOI: 10.1016/j.semarthrit.2021.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 52 publications
1
9
0
Order By: Relevance
“…An in ammatory process in the lungs can provoke autoimmune responses, such as the generation of citrullinated peptide antibodies against antigens released from activated neutrophils [8,13]. In agreement with previous studies reporting a high risk of bronchiectasis in other CTDs such as rheumatoid arthritis and Sjogren's syndrome [30,31], systemic and pulmonary in ammation may coexist and in uence each other in systemic sclerosis, which leads to the development of bronchiectasis. Third, the use of immunosuppressants in systemic sclerosis might be related to recurrent respiratory infection, which is an important cause of bronchiectasis [32].…”
Section: Discussionsupporting
confidence: 83%
“…An in ammatory process in the lungs can provoke autoimmune responses, such as the generation of citrullinated peptide antibodies against antigens released from activated neutrophils [8,13]. In agreement with previous studies reporting a high risk of bronchiectasis in other CTDs such as rheumatoid arthritis and Sjogren's syndrome [30,31], systemic and pulmonary in ammation may coexist and in uence each other in systemic sclerosis, which leads to the development of bronchiectasis. Third, the use of immunosuppressants in systemic sclerosis might be related to recurrent respiratory infection, which is an important cause of bronchiectasis [32].…”
Section: Discussionsupporting
confidence: 83%
“…[ 3 , 33 ] Compared with other connective tissue diseases (CTD), small airway diseases, including bronchiolitis obliterans, follicular bronchiolitis, and bronchiectasis, are more common in RA patients. [ 33 , 34 ] Some patients may have coexisting interstitial and small airways disease or diffuse bronchiectasis in RA [ 35 , 36 ] : a recent meta-analysis showed that the overall prevalence of bronchiectasis is between 18.7% and 22.6% among RA, and bronchiectasis is more common in RA-ILD (18.1%–30.0%) vs. RA without ILD (10.5%–20.0%). As ILD can be the first manifestation of RA, for patients with a UIP and/or NSIP pattern of ILD concomitant with bronchiectasis, screening for RA in the initial diagnostic algorithm and follow-up surveillance is recommended.…”
Section: Ra-associated Ildmentioning
confidence: 99%
“…The most common extra-articular manifestation of RA is lung involvement, which can affect up to 60% of patients with RA during the disease course [3]. Bronchiectasis is an established extraarticular manifestation of RA, which presents as irreversible damage to the bronchi along with widening and thickening resulting in exuberant mucus production [4]. Approximately 30% of RA patients demonstrate bronchiectasis on High-Resolution Computed Tomography, which can be asymptomatic and may precede or follow the development of RA [5][6][7].…”
Section: Introductionmentioning
confidence: 99%